SS

Suyash Sunil Bhakte

Active Director Director DIN 10526850
DIN 10526850 First appointment Feb 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Suyash Sunil Bhakte

Data last updated:

Suyash Sunil Bhakte is a Director at Shrek Medi Plus Pharmaceutical Private Limited (since 2024). The company operates in Pharma.

DIN 10526850
Primary Designation Director
Industry Pharma
First Appointment 28 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Feb 20242024Active

Board colleagues of Suyash Sunil Bhakte

Directorship timeline

Open interactive timeline →
Shrek Medi Plus Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Suyash Sunil Bhakte

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suyash Sunil Bhakte

Suyash Sunil Bhakte currently holds 1 directorship: Shrek Medi Plus Pharmaceutical Private Limited (Director, since 28 Feb 2024).

Suyash Sunil Bhakte was first appointed on 28 Feb 2024 as Director at Shrek Medi Plus Pharmaceutical Private Limited.

The current boards of Suyash Sunil Bhakte's companies include Ekta Sureshrao Thakare (Shrek Medi Plus Pharmaceutical Private Limited), Shrikant Ganesh Maske (Shrek Medi Plus Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available